
News|Articles|February 11, 2025
Unlocking the Power of Research-Ready Data for Life Sciences
Author(s)LexisNexis® Risk Solutions
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments
2
Novo Nordisk Launches Multi-Month Subscription Program for Wegovy
3
Merck Enters $838 Million Research & Development Collaboration with Infinimmune
4
How Will MFN’s Effects on Medicare Impact Innovation?
5